Corporate

October 16, 2012

Denosumab (Prolia, Xgeva) Update

Effective October 01, 2012, ICD-9-CM requirements have changed for Denosumab (Prolia). Covered diagnosis for this drug are; 198.5, 733.00, 733.01, 733.02, or 733.09.

Please refer to the CGS website at: http://www.cgsmedicare.com to view the Chemotherapy and Biological policy (L31836) and the Densumab article (A50745).


Two Vantage Way, Nashville, TN 37228 © CGS Administrators, LLC. All Rights Reserved